Chargement en cours...
Pretargeting for imaging and therapy in oncological nuclear medicine
BACKGROUND: Oncological pretargeting has been implemented and tested in several different ways in preclinical models and clinical trials over more than 30 years. Despite highly promising results, pretargeting has not achieved market approval even though it could be considered the ultimate theranosti...
Enregistré dans:
| Publié dans: | EJNMMI Radiopharm Chem |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer International Publishing
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5824696/ https://ncbi.nlm.nih.gov/pubmed/29503847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41181-017-0026-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|